No Data
No Data
Compass Pathways: Englebert's Appointment Effective July 8 >CMPS
Compass Pathways: Englebert's Appointment Effective July 8 >CMPS
Express News | Compass Pathways Appoints Lori Englebert as Chief Commercial Officer
Compass Pathways to Participate in Upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
LONDON, June 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that
Cantor Fitzgerald Reiterates Overweight on Compass Pathways
Cantor Fitzgerald analyst Charles Duncan reiterates Compass Pathways (NASDAQ:CMPS) with a Overweight.
Compass Pathways Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/21/2024 — Cantor Fitzgerald Reiterates → Overweight 05/13/2024 1791.73% HC Wainwright & Co. $120 → $12
Should You Buy the Dip on Compass Pathways Stock?